The preclinical results for RV-8451, an oral GLP-1 pill, will go on display as three posters at ObesityWeek in Washington, DC, in November. If you sat down to write a wish list for a weight-loss drug, ...
NeuroXT’s NEXT-Cue pairs brain MRI with cognitive scores to help clinicians assess patients with mild cognitive impairment. Picture the follow-up appointment after a diagnosis of mild cognitive ...
Prenuvo and UT Dallas researchers found links between sleep efficiency, visceral fat and brain volume, with long sleepers ...
Decades founder Eva Novak on why the blue zone idea can survive scrutiny, but only if validation becomes independent, open and repeated. In early October, a mountain village in central Sardinia was ...
A Biograph study using AI on routine heart CT scans found inflammation that cholesterol tests and risk calculators could not ...
Bio says its Activin E antibody kept weight loss closer to pure fat in monkeys on semaglutide, and could one day be dosed twice a year.
Fitnescity Health opens its 1,000-plus imaging locations to digital health platforms through one API, with Superpower on ...
United Therapeutics will test treprostinil SMI in about 40 patients with pulmonary hypertension linked to COPD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results